Skip to main content
. 2024 Mar 27;8(3):102390. doi: 10.1016/j.rpth.2024.102390

Table 7.

Incidence rates per 10,000 person-years and incidence rate ratios of venous thrombosis within all starters vs all switchers of combined oral contraceptives by follow-up duration in Denmark.

N of starters N of VT events among starters Person-years among starters IR of VT (per 10,000 person-years) in starters
(95% CI)
N of switchers N of VT events among switchers Person-years among switchers IR of VT (per 10,000 person-years) in switchers
(95% CI)
IRR (95% CI) among switchers vs starters (ref.) aIRRa (95% CI) among switchers vs starters (ref.)
Follow-up duration
1-3 855,617 273 205,174.78 13.31 (11.73-14.88) 82,929 33 19,782.98 16.68 (10.99-22.37) 1.25 (0.87-1.80) 1.50 (1.04-2.16)
4-6 569,599 181 133,920.87 13.52 (11.55-15.48) 59,453 10 13,735.51 7.28 (2.77-11.79) 0.54 (0.28-1.02) 0.59 (0.31-1.10)
7-9 469,344 102 108,615.89 9.39 (7.57-11.21) 47,752 8 10,989.85 7.28 (2.24-12.32) 0.78 (0.38-1.59) 0.84 (0.41-1.74)
10-12 393,303 66 91,349.75 7.22 (5.48-8.97) 39,527 10 9068.20 11.03 (4.19-17.86) 1.53 (0.78-2.97) 1.55 (0.79-3.03)

aIRR, adjusted incidence rate ratio; IR, incidence rate; IRR, incidence rate ratio; N, number; VT, venous thrombosis; Ref., reference.

a

Adjusted for age, obesity, and type of combined oral contraceptives.